Literature DB >> 25063436

Vascular access choice in incident hemodialysis patients: a decision analysis.

David A Drew1, Charmaine E Lok2, Joshua T Cohen3, Martin Wagner4, Navdeep Tangri5, Daniel E Weiner6.   

Abstract

Hemodialysis vascular access recommendations promote arteriovenous (AV) fistulas first; however, it may not be the best approach for all hemodialysis patients, because likelihood of successful fistula placement, procedure-related and subsequent costs, and patient survival modify the optimal access choice. We performed a decision analysis evaluating AV fistula, AV graft, and central venous catheter (CVC) strategies for patients initiating hemodialysis with a CVC, a scenario occurring in over 70% of United States dialysis patients. A decision tree model was constructed to reflect progression from hemodialysis initiation. Patients were classified into one of three vascular access choices: maintain CVC, attempt fistula, or attempt graft. We explicitly modeled probabilities of primary and secondary patency for each access type, with success modified by age, sex, and diabetes. Access-specific mortality was incorporated using preexisting cohort data, including terms for age, sex, and diabetes. Costs were ascertained from the 2010 USRDS report and Medicare for procedure costs. An AV fistula attempt strategy was found to be superior to AV grafts and CVCs in regard to mortality and cost for the majority of patient characteristic combinations, especially younger men without diabetes. Women with diabetes and elderly men with diabetes had similar outcomes, regardless of access type. Overall, the advantages of an AV fistula attempt strategy lessened considerably among older patients, particularly women with diabetes, reflecting the effect of lower AV fistula success rates and lower life expectancy. These results suggest that vascular access-related outcomes may be optimized by considering individual patient characteristics.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  dialysis access; hemodialysis; survival

Mesh:

Year:  2014        PMID: 25063436      PMCID: PMC4279737          DOI: 10.1681/ASN.2013111236

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  24 in total

Review 1.  Dialysis fistula or graft: the role for randomized clinical trials.

Authors:  Michael Allon; Charmaine E Lok
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-28       Impact factor: 8.237

2.  US Renal Data System 2010 Annual Data Report.

Authors:  Allan J Collins; Robert N Foley; Charles Herzog; Blanche Chavers; David Gilbertson; Areef Ishani; Bertram Kasiske; Jiannong Liu; Lih-Wen Mau; Marshall McBean; Anne Murray; Wendy St Peter; Haifeng Guo; Sally Gustafson; Qi Li; Shuling Li; Suying Li; Yi Peng; Yang Qiu; Tricia Roberts; Melissa Skeans; Jon Snyder; Craig Solid; Changchun Wang; Eric Weinhandl; David Zaun; Cheryl Arko; Shu-Cheng Chen; Frederick Dalleska; Frank Daniels; Stephan Dunning; James Ebben; Eric Frazier; Christopher Hanzlik; Roger Johnson; Daniel Sheets; Xinyue Wang; Beth Forrest; Edward Constantini; Susan Everson; Paul Eggers; Lawrence Agodoa
Journal:  Am J Kidney Dis       Date:  2011-01       Impact factor: 8.860

3.  Choice of vascular access among incident hemodialysis patients: a decision and cost-utility analysis.

Authors:  Hui Xue; Eduardo Lacson; Weiling Wang; Gary C Curhan; Steven M Brunelli
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-28       Impact factor: 8.237

4.  Risk factors associated with patency loss of hemodialysis vascular access within 6 months.

Authors:  Mauricio Monroy-Cuadros; Serdar Yilmaz; Anastasio Salazar-Bañuelos; Christopher Doig
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-24       Impact factor: 8.237

5.  Trends in patient characteristics and first-year medical costs of older incident hemodialysis patients, 1995-2005.

Authors:  Lih-Wen Mau; Jiannong Liu; Yang Qiu; Haifeng Guo; Areef Ishani; Thomas J Arneson; David T Gilbertson; Stephan C Dunning; Allan J Collins
Journal:  Am J Kidney Dis       Date:  2010-02-08       Impact factor: 8.860

6.  Excerpts from the US Renal Data System 2009 Annual Data Report.

Authors:  Allan J Collins; Robert N Foley; Charles Herzog; Blanche M Chavers; David Gilbertson; Areef Ishani; Bertram L Kasiske; Jiannong Liu; Lih-Wen Mau; Marshall McBean; Anne Murray; Wendy St Peter; Haifeng Guo; Qi Li; Shuling Li; Suying Li; Yi Peng; Yang Qiu; Tricia Roberts; Melissa Skeans; Jon Snyder; Craig Solid; Changchun Wang; Eric Weinhandl; David Zaun; Cheryl Arko; Shu-Cheng Chen; Frederick Dalleska; Frank Daniels; Stephan Dunning; James Ebben; Eric Frazier; Christopher Hanzlik; Roger Johnson; Daniel Sheets; Xinyue Wang; Beth Forrest; Edward Constantini; Susan Everson; Paul W Eggers; Lawrence Agodoa
Journal:  Am J Kidney Dis       Date:  2010-01       Impact factor: 8.860

7.  Hemodialysis access at initiation in the United States, 2005 to 2007: still "catheter first".

Authors:  Robert N Foley; Shu-Cheng Chen; Allan J Collins
Journal:  Hemodial Int       Date:  2009-09-16       Impact factor: 1.812

8.  Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access.

Authors:  Eduardo Lacson; Weiling Wang; Raymond M Hakim; Ming Teng; J Michael Lazarus
Journal:  Am J Kidney Dis       Date:  2008-10-18       Impact factor: 8.860

9.  Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis.

Authors:  Ronald L Pisoni; Charlotte J Arrington; Justin M Albert; Jean Ethier; Naoki Kimata; Mahesh Krishnan; Hugh C Rayner; Akira Saito; Jeffrey J Sands; Rajiv Saran; Brenda Gillespie; Robert A Wolfe; Friedrich K Port
Journal:  Am J Kidney Dis       Date:  2009-01-15       Impact factor: 8.860

10.  Change in vascular access and mortality in maintenance hemodialysis patients.

Authors:  Eduardo Lacson; Weiling Wang; J Michael Lazarus; Raymond M Hakim
Journal:  Am J Kidney Dis       Date:  2009-09-12       Impact factor: 8.860

View more
  27 in total

1.  Dialysis Vascular Access Intervention and the Search for Biomarkers.

Authors:  Karl A Nath
Journal:  J Am Soc Nephrol       Date:  2015-10-09       Impact factor: 10.121

2.  Dialysis: Reducing central venous catheter use in haemodialysis.

Authors:  Michael Allon
Journal:  Nat Rev Nephrol       Date:  2015-04-21       Impact factor: 28.314

3.  Reassessing Recommendations for Choice of Vascular Access.

Authors:  Timmy Lee; Michael Allon
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-18       Impact factor: 8.237

4.  Catheter last, fistula not-so-first.

Authors:  Jay B Wish
Journal:  J Am Soc Nephrol       Date:  2014-07-25       Impact factor: 10.121

5.  Association of Race and Ethnicity with Vascular Access Type Selection and Outcomes.

Authors:  Timothy P Copeland; Robert J Hye; Peter F Lawrence; Karen Woo
Journal:  Ann Vasc Surg       Date:  2019-08-30       Impact factor: 1.466

6.  Choice of Hemodialysis Access in Older Adults: A Cost-Effectiveness Analysis.

Authors:  Rasheeda K Hall; Evan R Myers; Sylvia E Rosas; Ann M O'Hare; Cathleen S Colón-Emeric
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-18       Impact factor: 8.237

Review 7.  The ESRD Quality Incentive Program-Can We Bridge the Chasm?

Authors:  Daniel Weiner; Suzanne Watnick
Journal:  J Am Soc Nephrol       Date:  2017-03-15       Impact factor: 10.121

8.  Vascular imaging for hemodialysis vascular access planning.

Authors:  Rita L McGill; Robin Ruthazer; Eduardo Lacson; Klemens B Meyer; Dana C Miskulin; Daniel E Weiner
Journal:  Hemodial Int       Date:  2016-11-20       Impact factor: 1.812

9.  Early Failure of Dialysis Access among the Elderly in the Era of Fistula First.

Authors:  Karen Woo; Dana P Goldman; John A Romley
Journal:  Clin J Am Soc Nephrol       Date:  2015-08-07       Impact factor: 8.237

10.  The Survival Benefit of "Fistula First, Catheter Last" in Hemodialysis Is Primarily Due to Patient Factors.

Authors:  Robert S Brown; Bhanu K Patibandla; Alexander S Goldfarb-Rumyantzev
Journal:  J Am Soc Nephrol       Date:  2016-09-07       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.